These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6129854)

  • 1. [Effect of memantine on central neurotransmitter systems. Review of the results].
    Maj J
    Arzneimittelforschung; 1982; 32(10):1256-9. PubMed ID: 6129854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacodynamics and pharmacokinetics of memantine].
    Wesemann W; Sontag KH; Maj J
    Arzneimittelforschung; 1983; 33(8):1122-34. PubMed ID: 6357202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Effect of memantine on spinal alpha-motoneurons and on the content of dopamine, noradrenaline and serotonin in the striatum and lumbar spinal cord].
    Sontag KH; Wand P; Schwarz M; Wesemann W; Osborne NN
    Arzneimittelforschung; 1982; 32(10):1236-40. PubMed ID: 6891222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of memantine on various neurobiological processes.
    Osborne NN; Beale R; Golombiowska-Nikitin K; Sontag KH
    Arzneimittelforschung; 1982; 32(10):1246-55. PubMed ID: 6185123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of apomorphine and 1,3-dimethyl-5-aminoadamantane (DMAA) on ponto-geniculo-occipital (PGO) waves in cats.
    Przewlocki R
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):201-7. PubMed ID: 1208229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of serotonin in the mechanism of central action of apomorphine.
    Grabowska M
    Pol J Pharmacol Pharm; 1976; 28(4):389-94. PubMed ID: 790347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):53-61. PubMed ID: 1099605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
    Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
    J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histofluorescence studies on the effect of 1,3-dimethyl-5-adamantanamine (D-145) on serotonin neurons in midbrain raphe nuclei.
    Smialowska M
    Pol J Pharmacol Pharm; 1976; 28(3):233-42. PubMed ID: 951305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT receptor regulation of neurotransmitter release.
    Fink KB; Göthert M
    Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems.
    Randrup A; Mogilnicka E
    Pol J Pharmacol Pharm; 1976; 28(6):551-6. PubMed ID: 1034919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydergine: interaction with the neurotransmitter systems in the central nervous system.
    Markstein R
    J Pharmacol; 1985; 16 Suppl 3():1-17. PubMed ID: 2869188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of Magnolia and Ziziphus extracts with selected central nervous system receptors.
    Koetter U; Barrett M; Lacher S; Abdelrahman A; Dolnick D
    J Ethnopharmacol; 2009 Jul; 124(3):421-5. PubMed ID: 19505549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of memantine on membrane properties and postsynaptic potentials in neurons of Aplysia californica].
    Klee MR
    Arzneimittelforschung; 1982; 32(10):1259-67. PubMed ID: 6295410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Change in dopamine and serotonin receptor sensitivity following chronic chlorpromazine administration].
    Zharkovskiĭ AM; Riago LK; Arro AG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1980; 30(1):165-8. PubMed ID: 7189932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
    Quack G; Hesselink M; Danysz W; Spanagel R
    J Neural Transm Suppl; 1995; 46():97-105. PubMed ID: 8821045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.